絞り込み

18384

広告

弔鐘の記憶 ある患者家族の手記 (日経サイエンス)

アルツハイマー病は妻の記憶と人生を奪い,私たち家族を苦しめた。私たちにそれを止められる手立てはなかった。医学にも――。 スタンフォード大学などでサイエンスライテ...

  1. 特集:アルツハイマー病 (日経サイエンス...
  2. [企業] 病因遺伝子の出鼻を挫く遺伝子標...
  3. 「叡王戦」異例の第9局で豊島竜王勝利「二...
  4. [企業] RocheがInflazome...

ニュース一覧

Drug-Induced Hypophosphatemia: Current Insights.

著者 Megapanou E , Florentin M , Milionis H , Elisaf M , Liamis G
Drug Saf.2019 Nov 27 ; ():.
この記事をPubMed上で見るPubMedで表示
この記事をGoogle翻訳上で見る Google翻訳で開く

スターを付ける スターを付ける     (42view , 0users)
Phosphate is actively involved in many important biochemical pathways, such as energy and nucleic acid metabolism, cellular signaling, and bone formation. Hypophosphatemia, defined as serum phosphate levels below 2.5 mg/dL (0.81 mmol/L), is frequently observed in the course of treatment with commonly used drugs, such as diuretics, bisphosphonates, antibiotics, insulin, and antacids. Furthermore, this undesired effect may complicate the use of several novel medications, including teriparatide, denosumab, parenteral iron, and antiviral and antineoplastic agents. This review addresses drug-associated hypophosphatemia, focusing on underlying mechanisms and the most recent knowledge on this topic, in order to increase the insight of clinicians, with reference to early diagnosis and appropriate management.
PMID: 31776845 [PubMed - as supplied by publisher]
印刷用ページを開く Endnote用テキストダウンロード